Header placeholder lorem ipsum dolor sit amet, consectetur adipiscing elit.
PAVmed financials data including stock price, CreditSafe score, income statement, balance sheet, and cash flow.
Stock Price
$1.1
2024-10-29
Market Capitalization
$10.5 M
2024-10-29
Revenue
$71 K
FY, 2025
CreditSafe Score
?
Score changed on Jun 06, 2026
Premium Content only available in Craft’s Intelligence Portal
View 30+ financial ratio metrics including price-to-earnings ratio, debt-to-assets ratio, gross profit margin, and more.
Financial ratio metrics help evaluate the financial strength of a company, and help raise red flags that can indicate potential risk, fulfillment challenges, or even possible bankruptcy.
Learn moreFinancial Statements
| USD | FY, 2016 | FY, 2017 | FY, 2018 | FY, 2019 | FY, 2020 | FY, 2021 | FY, 2022 | FY, 2023 | FY, 2024 | FY, 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 500.0K | 377.0K | 2.5M | 3.0M | 71.0K | |||||
| Cost of goods sold | 585.0K | 3.6M | 6.4M | 4.8M | 218.0K | |||||
| Gross profit | (85.0K) | (3.2M) | (1.8M) | (147.0K) | ||||||
| Gross profit margin, % | -858.6% | -61.3% | -207.0% | |||||||
| General and administrative expense | 3.9M | 5.4M | 6.3M | 7.7M | 12.4M | 25.6M | 41.0M | 30.9M | 24.5M | 16.3M |
| Operating expense total | 5.7M | 8.0M | 10.6M | 14.3M | 23.4M | 54.3M | 87.7M | 64.9M | 42.6M | 21.7M |
| Depreciation and amortization | 1.8M | 105.0K | ||||||||
| EBIT | (8.0M) | (10.6M) | (14.3M) | (23.4M) | (54.4M) | (90.9M) | (68.8M) | (44.5M) | (21.8M) | |
| EBIT margin, % | -24118.6% | -1482.9% | -30712.7% | |||||||
| Interest income | 505.0K | 254.0K | 29.0K | |||||||
| Interest expense | 589.0K | 45.0K | ||||||||
| Pre tax profit | (9.5M) | (18.2M) | (17.3M) | (35.9M) | (56.1M) | (103.2M) | (79.3M) | 28.4M | (2.5M) | |
| Net Income | (5.7M) | (9.5M) | (18.0M) | (17.3M) | (35.9M) | (56.1M) | (103.2M) | (79.3M) | 28.4M | (2.5M) |
| EPS | (9.0) | 0.5 | (5.6) |